Adjupanrix
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Adjupanrix, covering 2025-12-17 to 2025-12-17. Get the full timeline:
Most recent: EMA Authorised: Adjupanrix (previously Pandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted) GlaxoSmithKline Biologicals) (split influenza virus, inactivated, containing antigen: A/VietNam/1194/2004 (H5N1) like strain used (NIBRG-14)) — GlaxoSmithKline Biologicals S.A.